Understanding Your MDT Meeting
If you’ve recently been diagnosed with Leiomyosarcoma (LMS), your consultant may tell you that your case will be discussed at an MDT meeting.
For many people, that’s another unfamiliar term at an already overwhelming time.
The good news is that an MDT meeting is a routine and important part of cancer care. It brings together a team of specialists who work together to recommend the most appropriate treatment plan for your individual circumstances.
Rather than one doctor making decisions alone, several experts combine their knowledge and experience to ensure every aspect of your care is carefully considered.
What does MDT stand for?
MDT stands for Multidisciplinary Team.
This simply means a group of healthcare professionals from different specialties who meet regularly to discuss patients and agree the most appropriate treatment recommendations.
For people diagnosed with Leiomyosarcoma, having your case reviewed by an MDT is an important part of receiving specialist care.
Who attends an MDT meeting?
The exact team will vary depending on your circumstances, but it may include:
- Specialist sarcoma surgeons
- Medical oncologists
- Clinical oncologists
- Radiologists, who interpret scans
- Pathologists, who examine biopsy samples
- Clinical nurse specialists
- Other healthcare professionals involved in your care
Each person brings their own expertise, helping build a complete picture of your diagnosis and treatment options.
What happens during the meeting?
Before the meeting, the team will review all the available information about your diagnosis.
This may include:
- Scan results
- Biopsy findings
- Blood test results
- Your medical history
- Your general health
- The location and size of the tumour
Together, the team discusses this information before recommending the treatment approach they believe is most appropriate.
Although every patient’s situation is unique, the aim is always to ensure decisions are based on the combined expertise of the whole team.
Will I attend the MDT meeting?
No.
MDT meetings are meetings between healthcare professionals, so patients do not usually attend.
Afterwards, your consultant or another member of your healthcare team will explain the recommendations and discuss them with you.
This also gives you the opportunity to ask questions and understand why a particular treatment has been recommended.
Does the MDT make the final decision?
The MDT makes recommendations based on the available evidence and the expertise of the team.
Your consultant will then discuss these recommendations with you, taking into account your individual circumstances, preferences and any questions you may have before agreeing your treatment plan.
Your care should always be a shared conversation between you and your healthcare team.
Why are MDT meetings particularly important for Leiomyosarcoma?
Leiomyosarcoma is a rare cancer.
Because many hospitals see relatively few cases, specialist knowledge is incredibly important.
MDT meetings ensure that healthcare professionals with experience in sarcoma work together to consider each patient’s diagnosis and treatment options.
This collaborative approach helps ensure decisions are based on the latest evidence, specialist expertise and careful discussion.
Waiting for the MDT can feel difficult
Many people say that waiting to hear the outcome of their MDT meeting can be one of the hardest parts of the early weeks after diagnosis.
It’s natural to want answers as quickly as possible.
Although waiting can be frustrating, taking the time for your case to be reviewed by a team of specialists helps ensure the recommendations are based on all the available information.
Questions you might want to ask afterwards
After your MDT meeting, you may find it helpful to ask:
- What did the MDT recommend?
- Why is this treatment being recommended?
- Were there different treatment options discussed?
- Will I need any further tests before treatment begins?
- What happens next?
Writing questions down before your appointment can help you feel more confident during the discussion.
Remember, you’re not facing this alone
Although you won’t be in the MDT meeting itself, you are at the centre of every conversation.
The purpose of the MDT is to ensure the right experts are working together to recommend the best possible care for you.
While it may feel like another unfamiliar step, it is also a reassuring sign that your diagnosis is being carefully reviewed by professionals with experience in treating rare cancers like Leiomyosarcoma.
Related articles
- I’ve Just Been Diagnosed with Leiomyosarcoma. What Happens Next?
- What Questions Should I Ask My Consultant After a Leiomyosarcoma Diagnosis?
- What Is a Specialist Sarcoma Centre?
- How Is Leiomyosarcoma Diagnosed?
Please remember: Every person’s diagnosis and treatment pathway is different. This information is intended as general guidance and should not replace advice from your consultant or specialist healthcare team.